Exodus Point Capital Management, LP Ani Pharmaceuticals Inc Transaction History

Exodus Point Capital Management, LP

  • $16.4 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 11, 2022
SELL
$32.97 - $56.85 $209,194 - $360,713
-6,345 Closed
0 $0
Q3 2021

Nov 15, 2021
BUY
$26.48 - $35.99 $168,015 - $228,356
6,345 New
6,345 $208,000
Q3 2020

Nov 16, 2020
SELL
$26.38 - $33.1 $169,333 - $212,468
-6,419 Closed
0 $0
Q2 2020

Aug 14, 2020
BUY
$29.93 - $50.1 $192,120 - $321,591
6,419 New
6,419 $208,000

Others Institutions Holding ANIP

# of Institutions
211
Shares Held
18.8M
Call Options Held
11.7K
Put Options Held
10.5K
View Full List

About ANI PHARMACEUTICALS INC

ANIP Quotes by TradingView
  • Ticker ANIP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 17,426,000
  • Market Cap $986M
  • Description
  • ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations. The company manufactures oral solid dose produc...
More about ANIP
Track This Portfolio

Track Exodus Point Capital Management, LP Portfolio

Follow Exodus Point Capital Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Exodus Point Capital Management, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email